CryoPort Inc. (CYRX) Stock Rises on Q4 2025 Earnings

CryoPort Inc. (CYRX) reported results for the fourth quarter of 2025, with revenue of $45.45 million, down 59.8% year-over-year and slightly above the consensus estimate of $43.78 million.

Key income statement highlights:

Revenue: $45.45 million (down 59.8% YoY).

Gross profit: $21.71 million (down 56.1% YoY).

Cost of sales: $23.74 million (down 62.7% YoY).

Operating loss: $10.03 million (operating profit declined 54.3% YoY).

Net loss attributable to common shareholders: $13.64 million (down 34.0% YoY); diluted loss per share: $0.27.

Balance sheet and cash flow notes:

Cash and cash equivalents: $250.49 million, a large increase of 633.8% year-over-year.

Cash from operating activities: $2.19 million (down 139.9% YoY).

Capital spending on property, plant and equipment: $3.45 million (down 33.8% YoY).

Total liabilities: $262.35 million (down 13.0% YoY).

Market and expectations:

Revenue beat expectations while diluted earnings per share missed the estimate (reported loss per share of $0.27 vs. an expected loss of about $0.21).

Stock moved modestly after the release, changing by 1.31% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

CryoPort Inc. Insider Trading Activity

CryoPort Inc. insiders have traded $CYRX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CYRX stock by insiders over the last 6 months:

ROBERT J HARIRI sold 25,000 shares for an estimated $242,737
RAMKUMAR MANDALAM sold 11,570 shares for an estimated $115,540

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CryoPort Inc. Hedge Fund Activity

We have seen 78 institutional investors add shares of CryoPort Inc. stock to their portfolio, and 93 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BROWN CAPITAL MANAGEMENT LLC removed 1,509,073 shares (-57.6%) from their portfolio in Q4 2025, for an estimated $14,487,100
AXA S.A. removed 735,814 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,975,516
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 635,060 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,096,576
MILLENNIUM MANAGEMENT LLC added 623,896 shares (+23.8%) to their portfolio in Q4 2025, for an estimated $5,989,401
KENNEDY CAPITAL MANAGEMENT LLC removed 547,402 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,189,370
JACOBS LEVY EQUITY MANAGEMENT, INC removed 428,790 shares (-81.8%) from their portfolio in Q4 2025, for an estimated $4,116,384
MAK CAPITAL ONE LLC added 381,063 shares (+46.6%) to their portfolio in Q4 2025, for an estimated $3,658,204

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CryoPort Inc. Analyst Ratings

Wall Street analysts have issued reports on $CYRX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

UBS issued a "Buy" rating on 11/05/2025
BTIG issued a "Buy" rating on 09/18/2025

To track analyst ratings and price targets for CryoPort Inc., check out Quiver Quantitative's $CYRX forecast page.

CryoPort Inc. Price Targets

Multiple analysts have issued price targets for $CYRX recently. We have seen 3 analysts offer price targets for $CYRX in the last 6 months, with a median target of $12.5.

Here are some recent targets:

David Saxon from Needham set a target price of $12.0 on 11/05/2025
John Sourbeer from UBS set a target price of $12.5 on 11/05/2025
David Larsen from BTIG set a target price of $15.0 on 09/18/2025